What We're Reading: Page 161
Industry reads hand-picked by our editors
Feb 19, 2021
-
Bloomberg
A U.S. Vaccine Surge Is Coming, With Millions of Doses Promised
-
The New York Times
Clinical Trials Are Moving Out of the Lab and Into People’s Homes
-
The Wall Street Journal
IBM Explores Sale of IBM Watson Health
-
FierceBiotech
In conversation with John Leonard, CEO of Intellia
Feb 18, 2021
-
The Washington Post
Biden picks Chiquita Brooks-LaSure to run Medicare, Medicaid
-
Evaluate Vantage
The reckoning begins for biotech-focused Spacs
-
STAT
Covid crushed in-person pharma sales. Tech is pitching itself as a solution
-
Financial Times
Russia’s Covid vaccine faces global production hurdles
Feb 17, 2021
-
The Wall Street Journal
Insiders at Covid-19 Vaccine Makers Sold Nearly $500 Million of Stock Last Year
-
Endpoints News
After four decades, one researcher's radical HIV cure finally gets its shot
-
The BMJ
Why did a German newspaper insist the Oxford AstraZeneca vaccine was inefficacious for older people—without evidence?
-
Raleigh News & Observer
Humacyte goes public via SPAC for deal valued at $1.1B
Feb 16, 2021
Feb 12, 2021
-
Nature
This COVID-vaccine designer is tackling vaccine hesitancy — in churches and on Twitter
-
STAT
Amicus drug for Pompe disease falls short in key clinical trial
-
Endpoints News
All in on ide-cel, Bristol Myers Squibb writes off $470M as second BCMA CAR-T is ejected from the pipeline
-
The Washington Post
Drug companies seek billion-dollar tax deductions from opioid settlement
Feb 11, 2021
-
The New York Times
‘A Game Changer’: Drug Brings Weight Loss in Patients With Obesity
-
Reuters
Merck in talks with governments, other drugmakers to produce COVID-19 shots
-
The Wall Street Journal
Eli Lilly Doesn’t Plan to Claw Back Past Pay From Former CFO
-
Evaluate Vantage
2020 wins top of the froths for biotech stocks
Feb 10, 2021
-
The Wall Street Journal
SoftBank to Make $900 Million Investment in Pacific Biosciences
-
C&EN
The race to repurpose nature's protein factories
-
The New York Times
Could a Single Vaccine Work Against All Coronaviruses?
-
Endpoints News
With 'rapid' progress of pediatric brain cancer treatment, Day One sees broad excitement in new crossover round
Previous
